Cordyceps and immunity: a review of Das et al., 2021
Ukraine, Dnepr, st. 25 Sicheslavskaya Brigade (Rybinskaya St.), 119 ‑ 120
Ukraine, Dnepr, st. 25 Sicheslavskaya Brigade (Rybinskaya St.), 119 ‑ 120

Cordyceps and immunity: a review of Das et al., 2021

Das et al., 2021 review of cordyceps: how its compounds enhance and restrain immunity, what was described in humans for endurance and kidneys, who should see a doctor first.

Cordyceps and immunity: a review of Das et al., 2021
A review of Das et al. (Frontiers in Pharmacology, 2021): what is inside cordyceps, what its compounds do for immunity, endurance, the kidneys and metabolism, where each result was obtained (in humans, in animals or in a test tube), and who should consult a physician first.

Key points

Cordyceps is an insect-parasitizing fungus from Tibetan and traditional Chinese medicine; what its compounds do and where each result was obtained is set out in the review Das G, Front Pharmacol 2021 and in the table below.

AreaHow it helpsWhat studies in humans showed
Immunitythe fungus’s compounds both enhance the immune response and restrain an excessive one — an immunomodulator [preclinical]renal failure: better cellular immunity; after kidney transplant, a “cost-effective immunosuppressive agent” [humans · design not described]
Endurancemice given C. sinensis mycelium polysaccharides swam longer to exhaustion [animals]Cs-4, 12 weeks, healthy older adults: higher metabolic and ventilatory thresholds [humans · placebo-controlled]
Kidneyskidney function was preserved in mice with type 2 diabetes [animals]chronic renal failure: improved kidney function; after kidney transplant, less blood and protein in the urine; in older patients, kidney protection from aminoglycoside antibiotics [humans · design not described]
Inflammationless edema and fewer signs of colitis; lower NO, prostaglandin E2 and proinflammatory cytokines [animals · in vitro]—
Tumorscordycepin inhibits cancer cell proliferation; at low concentration it increased the sensitivity of gallbladder cancer cells to chemotherapy drugs [in vitro · animals]—
Blood sugar, lipids, blood pressurelower glucose and insulin, higher insulin sensitivity, lower lipids and blood pressure [animals]—
Male fertilitybetter sperm motility and morphology in boars and rats [animals]—

How it helps

How to read the labels

A label follows every statement about an effect on the body: it tells you in whom or in what the result was obtained. The closer a label is to the word “humans,” the closer the result is to the question “will this help me.” An RCT is a randomized controlled trial: groups are assigned at random; in a placebo-controlled trial the comparison is with a dummy pill.

LabelWhat it means
[traditional use]folk use; experience, not testing
[chemical analysis]what was found in the fungus; says nothing about the effect
[in vitro]cells in a test tube or dish
[in vitro · human cells]human cells, but the experiment is in a test tube
[animals]mice, rats and other animals
[preclinical]cells and/or animals; the review does not specify
[humans · design not described]people took part; the design is not reported
[humans · RCT] or [humans · placebo-controlled]controlled trials
[review authors’ opinion]an assumption, not the result of an experiment
[level not stated]not said in whom it was obtained

What is inside

The fungus contains dozens of groups of substances: nucleosides, sterols, flavonoids, cyclic peptides, phenolics, alkaloids, polysaccharides and others.

  • Cordycepin (3′-deoxyadenosine) is an almost exact copy of adenosine, missing one oxygen atom; it is notably abundant in C. militaris. [chemical analysis]
  • Because of its resemblance to adenosine, cordycepin is linked to intracellular targets, apoptosis and the cell cycle (Tuli et al., 2013b). [preclinical]
  • “Cordycepic acid” is in fact D-mannitol; C. sinensis contains 7–29% of it, depending on the growth stage. [chemical analysis] It is credited with effects in liver fibrosis, a diuretic effect and free-radical-scavenging properties. [level not stated]
  • Polysaccharides make up 3–8% of the fruiting body. Only β-(1→3)-glucan, galactosaminoglycan and proteopolysaccharide showed antitumor activity. [level not stated]
  • A polysaccharide fraction of C. sinensis mycelium switches macrophages from the M2 type (“healing”) to the M1 type (“attack”) via NF-κB (Chen W et al., 2010; 2012). [in vitro]

Immunity

The main topic of the review. Cordyceps, its extracts and compounds have been linked to production of the cytokines IL-1β, IL-2, IL-6, IL-8, IL-10, IL-12 and TNF-α. [preclinical] It has also been linked to enhanced phagocytosis, nitric oxide production via the enzyme iNOS, triggering of the inflammatory response via the MAPK signaling pathway and synergism with interferon-γ in cytokine production. [preclinical]

In plain words. Cytokines are signaling proteins of immune cells: IL stands for interleukins, TNF-α for tumor necrosis factor. Phagocytosis is the engulfing of microbes and particles by a cell. NK cells are “natural killers” of infected and tumor cells.

In plain words. It is more accurate to call cordyceps not a “stimulant” but an immunomodulator: under different conditions and in different extracts the effect goes in different directions. The authors themselves write that it “contains different compounds with the ability to strengthen the response of the immune system and also to control its exacerbated response.”

EnhancesRestrains
cytokines IL-1β, IL-6, TNF-α ↑NO, TNF-α, IL-12 ↓
phagocytosis ↑T-cell proliferation ↓
NK cells ↑immunosuppression after kidney transplant
  • C. militaris polysaccharides in mice with cyclophosphamide-suppressed immunity: lymphocyte proliferation and the phagocytic index increased (Wang M et al., 2012). [animals]
  • An acidic polysaccharide of C. militaris given intranasally to mice with influenza A: less virus in the lungs, higher survival; the same polysaccharide increased TNF-α, IFN-γ and NO in macrophages (Ohta et al., 2007). [animals · in vitro]
  • Methanol fractions of C. sinensis suppressed lymphocyte proliferation, NK cell activity and IL-2 and TNF-α production by human mononuclear cells (Kuo et al., 1996). [in vitro · human cells]
  • Aqueous extract of C. militaris suppressed NO, TNF-α and IL-6 production by activated macrophages (Jo et al., 2010). [in vitro]
  • Cordycepin and C. sinensis in human cells: at rest, IL-1β, IL-6, IL-8, IL-10 and TNF-α rise; after activation with PHA (phytohemagglutinin, a substance used in the laboratory to activate lymphocytes), IL-2, IL-4, IL-5, IL-12, IFN-γ and TNF-α fall (Zhou et al., 2008). [in vitro · human cells]

In humans, C. sinensis is described as improving cellular immunity in renal failure (Guan et al., 1992) and as a “cost-effective immunosuppressive agent” after kidney transplantation (Li et al., 2009). [humans · design not described] Respiratory infections (Lin, Li, 2011) are mentioned with a book as the source. [level not stated]

Jung et al., 2019: CBG-CS-2 mycelium (Paecilomyces hepiali), healthy adults, Korea; randomized and double-blind, according to its title in the reference list. [humans · RCT] The review reports that the trial assessed efficacy and safety. Separately, the review writes that CBG-CS-2 components enhance NK cell activity and phagocytosis. [level not stated]

Endurance

Cs-4 (C. sinensis) for 12 weeks in healthy older adults, a double-blind, placebo-controlled trial (Chen S et al., 2010): higher metabolic and ventilatory thresholds. [humans · placebo-controlled] According to the review, higher thresholds indicate better aerobic performance without fatigue in older people. This is the review’s strongest result by design among those with a described outcome.

Xiao et al., 1999: according to its title in the reference list, increased aerobic capacity in healthy older adults on Cs-4 (an abstract). [humans · design not described] The fungus’s reputation in sports: in 1993 world athletics champions spoke of a diet that included cordyceps (Kashyap et al., 2016). [level not stated]

  • Mice given C. sinensis mycelium polysaccharides swam longer to exhaustion (Li & Li, 2009; Yan et al., 2012). [animals]
  • Benefits “have also been observed in athletes”: the review attributes them to a rise in cellular ATP. [review authors’ opinion]

Kidneys

  • Kidney transplant patients (per the study title), long-term C. sinensis: less blood and protein in the urine (Ding et al., 2011). [humans · design not described]
  • Older patients (per the study title): kidney protection from aminoglycoside antibiotics (Bao et al., 1994). [humans · design not described]
  • Chronic renal failure: improved kidney function (Guan et al., 1992). [humans · design not described]
  • CmNo1 (fruiting body and mycelium of C. militaris) preserved kidney function in mice with type 2 diabetes (Yu et al., 2016). [animals]

Inflammation

  • Ethanol extract of C. militaris mycelium reduced carrageenan-induced edema and iNOS expression in macrophages (Won & Park, 2005). [animals · in vitro]
  • Aqueous extract of C. militaris in dextran sulfate–induced colitis: less weight loss, diarrhea, bleeding and mucosal damage (Han et al., 2011). [animals]
  • Cordycepin in BV2 microglial cells dose-dependently reduced NO, prostaglandin E2 and proinflammatory cytokines (Jeong et al., 2010). [in vitro] From these data the authors speak of “high potential” in neurodegenerative diseases. [review authors’ opinion]
  • C. sinensis compounds suppressed the release of superoxide anion and elastase by human neutrophils: IC50 0.45 and 1.68 μg/mL versus 38.32 and 31.98 for indomethacin, an anti-inflammatory drug used as the control (Yang et al., 2011). “Most of the compounds” outperformed indomethacin; the values are as given in the review. [in vitro · human cells] IC50 is the concentration at which the effect is inhibited by half: the smaller the number, the stronger the compound in a test tube.
  • A C. sinensis polysaccharide in tumor-bearing mice increased SOD and GPx (enzymes that neutralize free radicals) and lowered MDA, a marker of radical damage to fats (Chen et al., 2006). [animals]

Tumors and infections

  • Cordycepin inhibits cancer cell proliferation via A3 adenosine receptors and the Wnt pathway (Yoshikawa et al., 2004–2008). [in vitro · animals] As the review stresses, cordycepin acts through pathways “depending upon the cell type.”
  • At low concentration, cordycepin increased the sensitivity of gallbladder cancer cells to gemcitabine and 5-fluorouracil (Wu et al., 2014). [in vitro]
  • C. militaris inhibited the growth of T-cell lymphoma transplanted into mice (Park et al., 2017). [animals]
  • Individual compounds from different species inhibited E. coli, the malaria parasite Plasmodium, Mycobacterium tuberculosis and HIV-1 reverse transcriptase. [in vitro]

Blood sugar, lipids, blood pressure

  • A polysaccharide of C. sinensis mycelium lowered plasma glucose in mice when injected into the abdominal cavity; with oral intake the lowering was “slight” (Kiho et al., 1993). [animals]
  • CordyMax Cs-4 in rats: lower basal glucose and insulin, higher insulin sensitivity (Balon et al., 2002; Zhao et al., 2002). [animals]
  • A protein component of C. sinensis lowered mean arterial pressure in rats (Chiou et al., 2000). [animals]
  • A C. militaris polysaccharide lowered blood and liver lipids (Wang L et al., 2015). [animals]

Memory and mood

  • In old mice, C. sinensis improved learning and memory (Wang et al., 2004). [animals]
  • A supercritical extract of C. sinensis had an antidepressant-like effect in the mouse tail suspension test (Nishizawa et al., 2007). [animals]

Hormones and fertility

  • Cordyceps is called “Himalayan Viagra” in popular literature (Kashyap et al., 2016). [traditional use]
  • C. militaris mycelium improved sperm motility and morphology in subfertile boars and in rats (Lin et al., 2007; Chang et al., 2008). [animals]
  • Cordycepin increased testosterone in Leydig cells and in mouse plasma (Leu et al., 2011). [in vitro · animals]
  • In human granulosa cells, C. sinensis increased estradiol production (Huang B M et al., 2004). [in vitro · human cells]

In traditional medicine

The fungus is used in the folk medicine of Tibet, China, Nepal, Bhutan and India; in 1964 it was listed in the Chinese Pharmacopoeia.

  • In traditional Chinese medicine (TCM), a tonic for diseases of the respiratory tract, liver and kidneys, for high blood sugar and for tumors. [traditional use]
  • For energy, endurance, aerobic capacity and “cellular immunity”; for fatigue and weakness, and to ease the symptoms of altitude sickness. [traditional use]
  • TCM practitioners recommend regular intake of C. sinensis “to avoid infections, colds, and flues,” and for cough, asthma and bronchial diseases. [traditional use]

How to choose and take it

“Cordyceps” is not one fungus but hundreds of species with different compositions: the genus has more than 700. About 20 parasitize Elaphomyces fungi; the rest parasitize insects and arachnids. It grows in the mountains at 3,600–4,000 m. The best-studied species are C. sinensis (current name Ophiocordyceps sinensis) and C. militaris.

The fungus develops inside a living larva, replaces its tissues and emerges as a stalk, the fruiting body. Because of overharvesting the wild fungus has become scarce; since the 1970s scientists have been looking for ways to ferment and cultivate it, and C. militaris is considered a cheaper substitute for C. sinensis. Fungus from a mountain meadow and mycelium (the network of fungal threads) from a fermenter are different products. The review describes C. sinensis as a dietary supplement that complies with the requirements of the FDA, the US Food and Drug Administration (Wu et al., 2015): this refers to dietary supplement requirements, not to a proven therapeutic effect.

Each species has its own folk “specialty,” so the word “cordyceps” on a package without the species name tells you little.

Part of the fungusErgosterol, mg/gProtein, %
Mycelium1.4414.8 (fermenter)
Fruiting body10.6830.4
Dead larvae—29.1

In plain words. The fruiting body contains about 7 times more ergosterol than the mycelium, and twice as much protein as fermenter-grown mycelium (Li et al., 2011; Hsu et al., 2002). [chemical analysis] Each solvent “pulls out” its own set of substances, so a “cordyceps extract” in one study and in another are different mixtures.

Tradition has no single dose: local healers choose the dose and route “by trial and error” (Maity, 2013). [traditional use]

Who should see a doctor first

If you take immunosuppressants or have a transplanted organ, discuss taking cordyceps with your treating physician. If you are receiving chemotherapy, discuss taking cordyceps with your treating physician in advance. The same applies if you take blood thinners, glucose-lowering or blood pressure–lowering drugs: such combinations in humans were not studied in the review. Men with prostate cancer, or with suspected prostate cancer, should discuss taking cordyceps with their physician.

If you have a hormone-dependent condition, discuss taking cordyceps with your physician.

If you already take cordyceps or are considering it, tell your treating physician, especially if you have any of the conditions listed.

Combination with drugs

  • C. sinensis together with cyclosporin A in kidney transplantation (Ding et al., 2009). [level not stated]
  • Cordycepin increased the sensitivity of cancer cells to gemcitabine and 5-fluorouracil. [in vitro]
  • Polysaccharides with chemotherapy drugs: “synergism.” [animals]
  • Among the proposed applications of cordyceps, the review lists anti-thrombotic and anticoagulant effects (Qian et al., 2012; Liu Y et al., 2015). [level not stated]
  • Lowering of blood sugar in mice and rats, and of mean arterial pressure in rats. [animals]

The review gives no data on drug interactions in humans. But everything listed is a signal that the fungus’s components may alter how drugs work. If blood-thinning, glucose-lowering and blood pressure–lowering effects exist in humans, they may add to the action of drugs with the same purpose.

What is known about safety

  • “These properties are concentration-dependent, and in most cases, no adverse effects were reported, although the evaluation of isolated compounds such as cordycepin is preferred.” [review authors’ opinion]
  • The only RCT (Jung et al., 2019) also assessed safety, but the review gives no data on adverse effects. [humans · RCT]
  • Not all of the substances found are “beneficial”: they include immunosuppressants. Cyclosporin has been found in the species Cordyceps subsessilis (Segelken, 1996). [chemical analysis] C. sinensis has been used as a “cost-effective immunosuppressive agent” after kidney transplantation (Li et al., 2009). [humans · design not described]
  • In mice, C. sinensis increased testosterone and the androgen receptor and accelerated the growth of prostate cancer cells (Ma et al., 2018). [animals] In LNCaP human prostate cancer cells, apoptosis and autophagy have been described (Lee et al., 2014). [in vitro · human cells] The data contradict each other, and cell experiments do not show what will happen when a person takes the fungus.
  • Rugulosin and skyrin from C. formosana in CHO cells (a non-tumor line from Chinese hamster ovary): LD50 18.3 ± 0.2 and 103.7 ± 5.9 μg/mL (Lu et al., 2014). [in vitro] LD50 is the dose that kills half of the test subjects.
  • “New toxicological studies are needed to ensure their safety.” [review authors’ opinion]

Conclusion. “Not reported” does not mean “safe.” The review contains no frequencies of adverse effects, doses or durations of use in humans. It does not say how adverse effects were monitored in any of the human studies.

Bottom line

Cordyceps is a fungus of Tibetan and traditional Chinese medicine with dozens of groups of substances: cordycepin, polysaccharides, sterols and others. The Das et al., 2021 review has collected a broad map of its effects: in cells and animals the fungus’s compounds both enhance and restrain the immune response, reduce inflammation, inhibit cancer cell proliferation and lower blood sugar, lipids and blood pressure [preclinical]; in humans, higher endurance thresholds in healthy older adults on Cs-4 [humans · placebo-controlled] and studies with kidney patients [humans · design not described]. If you have any of the conditions in “Who should see a doctor first,” discuss taking it with your physician first.

The full guide is 89 pages laid out for a phone screen: all nine sections, a glossary and the list of human studies from the review — download the PDF.

Read also the second guide, Cordyceps and Arrhythmias: A Review of Wang et al., 2022, and the article on why wild Himalayan and lab-grown cordyceps are two different products.

Source: Cordyceps and immunity: a review of Das et al., 2021 — universum.earth. Dr. Pereligyn.

Come back
Request a call back